…
Davis is leading a global push to root out the molecular basis of what is laying waste to Whitney.
…
One of their inventions, a “nanoneedle” for testing blood, speaks to the need to find a single biomarker in patients’ blood.
…
Davis’ team has tested their nanoneedle with initial success and recently published their findings in a scholarly journal. They discovered ME/CFS patients’ blood responds to the introduction of “stress” — in this case, salt — differently than the blood of healthy people. Davis hopes the device will ultimately produce a cheap clinical test by which doctors can identify ME/CFS quickly and accurately.
He also wants to explore measures to prevent the disease. For example, he wants to understand why people with mononucleosis often develop ME/CFS.
Those are just a few of many things Davis’ team are working on.
Read full, original post: He pioneered technology that fueled the Human Genome Project. Now his greatest challenge is curing his own son